CardioEA(TM) Enhanced With Aspirin: A New Way to Help Reduce Heart Disease Risk Factors -- Now Widely Available
Posted on: Monday, 15 May 2006, 12:05 CDT
BOCA RATON, Fla., May 15 /PRNewswire/ -- CardioEA(TM) Enhanced with Aspirin provides consumers with a new option to help reduce heart disease risk factors. This innovation for complete heart health combines the known benefits of doctor-recommended, low-dose aspirin with vitamins, herbs, and other heart health supplements.
"What makes CardioEA Enhanced with Aspirin different is that it combines low-dose aspirin and known heart health vitamins and other supplements in a single daily caplet which can help manage multiple cardio risk factors," said Andre Landau, M.D., Cardiologist. "Its ingredients have been clinically shown to reduce cholesterol, lower blood pressure, and reduce the chances of heart attack and stroke in men and women."
CardioEA Enhanced with Aspirin contains 81 mg of doctor-recommended, low- dose aspirin plus a complex of Vitamins B6, B12, Folic Acid, L-Arginine and Aged Garlic Extract(TM) (AGE).
CardioEA Enhanced with Aspirin is the first in a new category of preventive and wellness products called OTCeuticals(TM) -- vitamins, minerals, herbs and other supplements that are combined with FDA monographed, Category 1 USP grade ingredients in rational, safe, effective and convenient combinations. CardioEA Enhanced with Aspirin is now available in the vitamin section at most major supermarkets, chain drug and discount retailers.
Developed and trademarked by the Alan James Group, OTCeuticals are preventive and wellness products developed for health-conscious consumers. Other OTCeuticals in their pipeline include products for bone and joint, and gastrointestinal health, among others.
The Alan James Group is a healthcare-focused consumer products company based in Boca Raton, Florida. The company is mindful of science and is constantly vigilant and cognizant of pioneering research and medicine in the development of its products. Paramount in the formulation and development of its range of products is the Alan James Group's total commitment to safety and efficacy on behalf of consumers.
Alan James Group
CONTACT: Lisa Packer, +1-610-688-3164, Lisa@robinsonpacker.com, for AlanJames Group
Source: PRNewswire
Related Articles
- Wayne State University Announces Positive Lipid Oxidation Test Results for Potential Management of Oxidative Stress Using Health Enhancement Products' ProAlgaZyme(TM) Filtrates
- Health Enhancement Products Reacquires ProAlgaZyme(TM) Distribution and Marketing Rights
- Alan James Group Launches Enhanced Websites for Existing Nutritional Supplement Product Line
- Health Enhancement Products Finalizes Settlement With the SEC and Undergoes Management Change
- Health Enhancement Products Releases Preliminary HIV and Metabolic Syndrome Clinical Study Results
- Health Enhancement Products Inc. Files International Patent Application to Protect Worldwide Rights to ProAlgaZyme
- Health Enhancement Products Receives Approval to Commence HIV and CRP Clinical Trial in Cameroon
- Health Enhancement Products Announces Appointment of Ex-White House Chief of Staff, Hamilton Jordan, to Its Scientific Advisory Board; Jordan to Also Act As a Consultant to the Company
- Health Enhancement Products Announces Laboratory Analysis Indicates PAZ Contains a Substance Associated With Appetite Suppression; The Analysis Showed a Possible Reason for Weight Loss Properties
- Health Enhancement Products Files for Patent Covering ProAlgaZyme Product
 |
 |
User Comments (0)
RSS Feeds